Home › Insurers scrutinize drug costs after $84,000 Sovaldi surprise
 

Keywords :   


Insurers scrutinize drug costs after $84,000 Sovaldi surprise

2014-05-29 02:40:22| Biotech - Topix.net

Shocked by the rapid adoption of a new US$84,000 hepatitis C treatment, U.S. health insurers are trying to make sure they aren't blindsided by other drugs being developed and are looking for ways to limit their use from the day they are launched.

Tags: costs drug surprise insurers

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Registration Now Open for RadTech 2025
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 7A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
More »